Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test \u2013 costing just \u00a310 \u2013 could ensure patients receive timely life-saving treatment.
A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.
Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.
Congratulations to Professor Gero Miesenb\u00f6ck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.
Cancer Research UK and the National Institute for Health and Care Research are investing over \u00a33 million across the next five years into The University of Oxford\u2019s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.
It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the \u20182022 INTERCOVID Study\u2019 conducted in 41 hospitals across 18 countries.
A consortium led by Matthew Wood, Professor of Neuroscience in the Department of Paediatrics and Director of the Oxford-Harrington Rare Disease Centre, has been awarded \u00a38m of funding from UKRI, LifeArc and the Nucleic Acid Therapy Accelerator (NATA) via the Nucleic Acid Therapies (NAT) Delivery Research Challenge.
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 \u2013 the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.
Professor Knight's research focuses on the care and prevention of severe complications of pregnancy and early life and addressing disparities in outcomes for women and babies from different population groups.
A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
Photographer in Residence at Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, Pearl Gan's photograph is featured as one of the winners in The Lancet's Highlights 2022. Highlights is The Lancet's annual photography competition and this year's competition focussed on health-related topics.
New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient\u2019s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
More than 40,000 doses of Oxford\u2019s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
Every day, thousands of parents and grandparents are diagnosed with serious health conditions such as cancer, lung or heart disease. They are then faced with the unenviable task of sharing this information with the children they love.
Nearly one in 10 young people are experiencing both persistent physical pain and suicidal feelings, according to a new paper from researchers from the University of Oxford, Cambridge, Oslo (Norway), King\u2019s College London, and the Parc Sanitari Sant Joan de Deu (Spain).
A study published today in 'Family Practice', led by researchers at the University of Oxford, finds that when doctors tell patients living with obesity to lose weight, the guidance they give is generally vague, superficial, and commonly not supported by scientific evidence.
![\"NPY](\"https://www.medsci.ox.ac.uk/news/new-blood-test-could-save-lives-of-heart-attack-victims/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n